2 assistance programs for Injectafer patients · 2 open today
Two American Regent programs: the Injectafer Savings Program, a $50-per-dose commercial copay card capped at four doses a year, and DS Access Central, free drug for uninsured patients or those with a coverage gap. Neither reaches a Medicare patient's coinsurance.
Select the patient's insurance to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links · verified July 16, 2026
Injectafer · IDA, oral iron failed or not tolerated · Commercial insurance
Eligible patients may pay $50
Example · Injectafer · 750 mg · 750 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With Injectafer Savings Program | |
|---|---|---|
| Drug responsibility | $169.80 | $50.00 |
| Administration (96374) | $7.55 | $7.55 |
| Patient owes | $177.35 | $57.55 |
Estimated patient savings: $119.80
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Also available if this patient’s coverage falls short
Free DS Access Central Patient Assistance (Free Drug) for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
| Task | ✓ |
|---|---|
| Find programs for the patient's insurance | ✓ |
| See whether the program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance — The Injectafer Savings Program is American Regent's copay card: patients pay $50 per dose, and the program pays up to $500 per dose, up to $2,000 per calendar year, capped at four doses per calendar year. It excludes Medicare, Medicaid, TRICARE, any other federal health care program, and Medicare-eligible retirees on an employer plan. It covers the drug only — the 96374 administration fee and the office visit are billed separately. View current program ↑
Uninsured or a coverage gap — DS Access Central ships Injectafer free directly to the provider for patients who are uninsured or have a coverage gap, at or below 500% of the federal poverty level, with no cap on the number of doses. The shipment is the drug alone — the office visit and the 96374 push fee still go on the patient's bill.
Medicare — Manufacturer copay savings cannot be used when government insurance is paying for Injectafer; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons, and it is also why the Injectafer Savings Program excludes Medicare-eligible retirees on an employer plan. DS Access Central is not a fallback either: its eligibility is limited to patients who are uninsured or have a coverage gap. On a 750 mg visit, a Medicare patient's 20% coinsurance is $177.35 on $886.74 allowed against $57.55 with the card ($50 for the drug plus the $7.55 share of the push) — three times as much.
Why the diagnosis selector doesn't change the result — Neither Injectafer program is gated by diagnosis. Eligibility runs on the patient's insurance status, and on household income for DS Access Central. IDA with oral iron failure (D50.9), non-dialysis CKD (D63.1), and heart failure (E61.1) all qualify the same way for whichever program matches the patient's insurance.
Yes. The Injectafer Savings Program is American Regent's commercial-only copay card: patients pay $50 per dose, and the program covers up to $500 per dose, up to $2,000 per calendar year, capped at four doses per calendar year. It excludes Medicare, Medicaid, TRICARE, any other federal health care program, and Medicare-eligible retirees on an employer plan. It covers the drug only, not the 96374 administration fee or the office visit. Apply on injectafercopay.com ↗ Calculate cost with the program →
No. The Injectafer Savings Program excludes Medicare, Medicaid, TRICARE, and any other federal health care program, plus Medicare-eligible retirees on an employer plan. On a 750 mg visit, a Medicare patient's 20% coinsurance is $177.35 on $886.74 allowed against $57.55 with the card ($50 for the drug plus the $7.55 share of the push) — three times as much. DS Access Central is not a Medicare fallback either: its eligibility is limited to patients who are uninsured or have a coverage gap. Check current options ↑
Patients who are uninsured or have a coverage gap, at or below 500% of the federal poverty level. DS Access Central ships Injectafer free directly to the provider with no cap on doses — no insurance billing involved. It covers the drug only; the office visit and the 96374 administration fee are billed separately. Apply on ar-assist.com ↗
Up to four doses per calendar year. Each dose caps the program's payment at $500, and the program's total payout is capped at $2,000 per calendar year — two doses cover a standard 1,500 mg course with room to spare if a second course is needed the same year. Call 1-877-448-4766 for enrollment questions.
No. Both the Injectafer Savings Program and DS Access Central cover the drug only. The 96374 push administration fee, $37.74 at the Medicare rate, and any office visit are billed separately, whichever program the patient uses.
Data current: programs verified Jul 16, 2026
Injectafer Savings Program (American Regent, injectafercopay.com) · DS Access Central Patient Assistance (American Regent, ar-assist.com/injectafer). Every program links directly to its official source or application page.
Last program check: .
Reviewed September 19, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost